Chemicals

5-Octanoylsalicylic acid

We are 5-Octanoylsalicylic acid CAS:78418-01-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 78418-01-6

Product Name: 2-Hydroxy-5-octanoylbenzoic acid

Other Name:

2-Hydroxy-5-octanoylbenzoic acid

5-Octanoylsalicylic acid

2-Hydroxy-5-octanoylbenzoic acid

5-N-octanoylsalicylic acid

capryloyl salicylic acid

Density: 1.1±0.1 g/cm3

Boiling Point: 454.8±35.0 °C at 760 mmHg

Molecular Formula: C15H20O4

Molecular Weight: 264.317

Flash Point: 243.0±22.4 °C

Exact Mass: 264.136169

PSA: 74.60000

LogP: 5.41

Vapour Pressure: 0.0±1.2 mmHg at 25°C

Index of Refraction: 1.544

Specification

Appearance: White crystalline powder

Assay: ≥99.0%

Residue on ignition: ≤0.4%

Application

It has a whitening and lightening effect, improves skin moisturizing ability, and improves skin elasticity.

Caprylyl salicylic acid is used as a cuticle separating agent, acne remover, whitening agent, anti-aging agent, and is used in cosmetics and skin medicinal ingredients.It can especially improve the clinical manifestations of skin aging-often called wrinkles and fine lines. It also restores skin that has lost firmness and elasticity.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

5-Octanoylsalicylic acid

Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.N-cyclohexyl-N-[2-(4-methyl-1-oxa-4-azoniacyclohex-4-yl)ethyl]methanediimine,4-methylbenzenesulfonic acid CAS:2491-17-0 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.N – [(4-fluorofenil) metil] -1-metilpiperidin-4-amina CAS:359878-47-0 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.402936-15-6 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.

Product Name
3-(Dimethoxymethylsilyl)propylamine	View Details
(2-Fluoro-1,1-cyclopropanediyl)dimethanol Cas:1822851-79-5	View Details
3-Chloropropyne	View Details